Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| astrocyte | 4 studies | 23% ± 6% | |
| oligodendrocyte | 4 studies | 21% ± 3% | |
| endothelial cell | 3 studies | 24% ± 4% | |
| GABAergic neuron | 3 studies | 43% ± 8% | |
| glutamatergic neuron | 3 studies | 51% ± 10% | |
| oligodendrocyte precursor cell | 3 studies | 27% ± 5% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 37% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 1787.24 | 245 / 245 | 100% | 11.41 | 502 / 502 |
| brain | 100% | 927.62 | 2634 / 2642 | 100% | 11.46 | 705 / 705 |
| breast | 100% | 1751.29 | 459 / 459 | 100% | 9.35 | 1113 / 1118 |
| thymus | 100% | 2055.99 | 653 / 653 | 99% | 8.61 | 600 / 605 |
| kidney | 100% | 1056.79 | 89 / 89 | 99% | 8.24 | 890 / 901 |
| lung | 100% | 1979.75 | 578 / 578 | 97% | 8.00 | 1122 / 1155 |
| ovary | 100% | 1872.84 | 180 / 180 | 97% | 5.88 | 417 / 430 |
| pancreas | 100% | 814.70 | 327 / 328 | 97% | 7.18 | 173 / 178 |
| adrenal gland | 100% | 1369.90 | 258 / 258 | 96% | 9.56 | 221 / 230 |
| liver | 100% | 1110.70 | 226 / 226 | 96% | 6.68 | 388 / 406 |
| uterus | 100% | 1599.81 | 170 / 170 | 93% | 6.01 | 425 / 459 |
| skin | 100% | 1349.01 | 1805 / 1809 | 92% | 7.26 | 434 / 472 |
| bladder | 100% | 1405.57 | 21 / 21 | 91% | 5.33 | 461 / 504 |
| esophagus | 100% | 1245.23 | 1441 / 1445 | 80% | 4.94 | 147 / 183 |
| stomach | 100% | 1134.88 | 358 / 359 | 79% | 4.18 | 227 / 286 |
| intestine | 100% | 1539.29 | 966 / 966 | 77% | 3.85 | 404 / 527 |
| blood vessel | 100% | 1431.12 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 5.85 | 29 / 29 |
| spleen | 100% | 1846.43 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 2.49 | 1 / 1 |
| adipose | 100% | 1687.35 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| heart | 99% | 1077.32 | 852 / 861 | 0% | 0 | 0 / 0 |
| muscle | 99% | 845.26 | 793 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 91% | 4.54 | 41 / 45 |
| eye | 0% | 0 | 0 / 0 | 83% | 4.42 | 66 / 80 |
| peripheral blood | 66% | 545.10 | 614 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007023 | Biological process | post-chaperonin tubulin folding pathway |
| GO_0007021 | Biological process | tubulin complex assembly |
| GO_0000226 | Biological process | microtubule cytoskeleton organization |
| GO_0005856 | Cellular component | cytoskeleton |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0043014 | Molecular function | alpha-tubulin binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | TBCEL |
| Protein name | Leucine rich repeat containing 35, isoform CRA_c (Tubulin folding cofactor E like) Tubulin-specific chaperone cofactor E-like protein (EL) (Leucine-rich repeat-containing protein 35) Leucine rich repeat containing 35, isoform CRA_a (Tubulin folding cofactor E like) (cDNA FLJ14177 fis, clone NT2RP2003161, highly similar to Tubulin-specific chaperone cofactor E-like protein) Tubulin folding cofactor E like Tubulin folding cofactor E-like |
| Synonyms | LRRC35 hCG_16245 |
| Description | FUNCTION: Acts as a regulator of tubulin stability. . |
| Accessions | ENST00000683345.1 E9PNS0 Q5QJ74 ENST00000533712.5 ENST00000422003.6 ENST00000524726.1 ENST00000529397.5 B3KNB6 ENST00000531148.5 G3V147 Q0VAN5 ENST00000284259.11 ENST00000533134.1 E9PP54 |
